R&D Trends

Harmac to create 100 jobs in Ireland

Monday, May 16, 2011 12:42 PM

U.S. medical device maker Harmac will create 100 new jobs as part of an expansion in Roscommon, Ireland, says Fierce Medical Devices.

More... »

Rules-Based Medicine partners with Institut Pasteur

Friday, May 13, 2011 11:50 AM

Texas-based Rules-Based Medicine (RBM), a provider of multiplexed protein biomarker services will be a collaborator on the Institut Pasteur research project Milieu Interieur (the environment within), funded through a LabEx grant from the French government.  The project will rely on RBM's TruCulture, an innovative in vitro model that preserves physiological cellular interactions, to more accurately describe the complexities of the human immune system.

More... »

BSHRI discovers new evidence in Alzheimer’s disease research

Friday, May 13, 2011 11:46 AM

Researchers at Banner Sun Health Research Institute (BSHRI) have found further evidence linking copper to the increased probability of developing Alzheimer's disease, according to a recent study published in the International Journal of Alzheimer's Disease. 

More... »

FDA drug approvals on the rise despite slow development time

Wednesday, May 11, 2011 01:02 PM

The FDA has passed nearly twice as many biopharmaceutical drug approvals in the last 10 years than it did in the 1990s, a news release from the Tufts Center for the Study of Drug Development (CSDD) has indicated, according to Mass High Tech.

More... »

Quotient, KWS partner in antimicrobial drug discovery

Tuesday, May 10, 2011 12:25 PM

Two U.K.-based providers of early-stage and other drug development services, Quotient Bioresearch and KWS BioTest, have partnered to offer coordinated “plate to patient” support for clients engaged in the discovery and development of new antimicrobial agents, according to Pharma Times.

More... »

Takeda invests in Fate Therapeutics

Tuesday, May 10, 2011 12:22 PM

Japan-based Takeda has made a strategic investment in the U.S.-based Fate Therapeutics, a privately-held firm that specializes in stem cell research, according to Pharma Times.

More... »

InVivo Therapeutics and The Miami Project to Cure Paralysis form strategic research collaboration

Thursday, May 5, 2011 11:45 AM

InVivo Therapeutics, a company focused on the development of technologies for the treatment of spinal cord injuries (SCI), and The University of Miami Miller School of Medicine's Miami Project to Cure Paralysis, a spinal cord injury research center, have entered into a strategic research collaboration for the development of novel SCI treatments.

More... »

Novartis CEO unveils drug development strategy

Wednesday, May 4, 2011 12:43 PM

During a recent interview with Fortune, Novartis CEO Joe Jimenez explained the company's drug development strategy. He reported that Novartis isn’t targeting blockbuster indications but are more focused on pathways, as reported in Fierce Biotech.

More... »

Allergan and Molecular Partners enter into license agreement

Wednesday, May 4, 2011 12:29 PM

Allergan and Molecular Partners have entered into a license agreement for MP0112, a phase II proprietary therapeutic DARPin(r) protein targeting VEGF under investigation for the treatment of retinal diseases.

More... »

Techne buys Tocris Holdings

Tuesday, May 3, 2011 01:16 PM

U.K. based Techne Corporation has acquired 100% ownership of another U.K.-based company, Tocris Holdings, a leading supplier of reagents for non-clinical life science research.  Tocris' products are used in both in-vitro and in-vivo experiments, to understand biological processes and diseases. The business is focused on making biologically active neuro- and bio-chemicals which are used by researchers to elucidate biological processes and pathways. The products are used in life-science research activities and as part of the initial drug discovery process.

More... »